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Abstract
Histone deacetylase 4 (HDAC4) has been associated with muscle & bone development [1–6]. N-terminal MEF2 and RUNX2
binding domains of HDAC4 have been shown to mediate these effects in vitro. A complete gene knockout has been
reported to result in premature ossification and associated defects resulting in postnatal lethality [6]. We report a viral
insertion mutation that deletes the putative deacetylase domain, while preserving the N-terminal portion of the protein.
Western blot and immuno-precipitation analysis confirm expression of truncated HDAC4 containing N-terminal amino acids
1-747. These mutant mice are viable, living to at least one year of age with no gross defects in muscle or bone. At 2–4
months of age no behavioral or physiological abnormalities were detected except for an increased latency to respond to a
thermal nociceptive stimulus. As the mutant mice aged past 5 months, convulsions appeared, often elicited by handling.
Our findings confirm the sufficiency of the N-terminal domain for muscle and bone development, while revealing other
roles of HDAC4.
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Introduction
HDAC4 (histone deacetylase 4) is a member of the class IIa
histone deacetylase family, which also includes HDAC5, HDAC7
and HDAC9. Class IIa histone deacetylases are defined [7] by
having an extended N-terminal domain that interacts with specific
transcription factors [4,6,8] in addition to a C-terminal deacetylase
domain [9–11]. This class also contains cell signal responsive
elements that affect nucleo-cytoplasmic shuttling [12–14] as well as
cell-type restricted expression [15]. HDAC4 has been extensively
studied, in vitro, with regards to the functions of the various domains,
theirinteractions,and theeffectofcellsignaling eventsonitsnuclear
import-export. Extensive deletion analysis [4,6,8] coupled with in
vitro assays have established that amino acids (aa) 1–660 is sufficient
to interact with MEF2, Runx2, HDAC1, 14-3-3, and also for
phosphorylation and nuclear export [3,12,13,16–19].
In vivo, HDAC4 in concert with RUNX2, has been shown to be
critical for bone development. HDAC4 null animals [6] have
premature ossification of endochondral bone due to chondrocyte
hypertrophy during development and do not survive to weaning.
On the other hand, over-expression of HDAC4 resulted in
inhibition of chondrocyte hypertrophy with delayed ossification
[6]. These effects mirror the phenotype seen in RUNX2 null
animals where ossification is delayed, while over-expression leads
to premature ossification [20–22].
More recently a conditional knockout approach adopted to
create a MEF2C deficit exclusively in different skeletal elements
identified a critical function of MEF2C along with HDAC4 in
bone development beyond their known role in muscle develop-
ment [1]. The effect of MEF2C deficit on bone formation is
mediated through interactions with HDAC4 such that the
precocious ossification in HDAC4 null animals is mostly rescued
by a single allele deletion of MEF2C. Conversely the MEF2C +/2
phenotype of delayed ossification is shown to be rescued by
deletion of the repressing HDAC4 [1]. Thus HDAC4 repression of
RUNX2 and MEF2C is critical for normal bone development.
Most in vitro studies have identified the N-terminal region as
being sufficient for HDAC4 functions in transcription repression,
phosphorylation and nucleocytoplasmic shuttling. In contrast, the
function of the deacetylase domain of HDAC4 is less clear [9–11].
Recently it has been shown, in vitro, to have a 1000 fold lower
activity than class I enzymes against conventional substrates [11].
Activity against novel substrate, trifluoroacetamide, has been
reported, but evidence is lacking for a physiological endogenous
substrate. However, the putative deacetylase domain of HDAC4
has been shown to bind and recruit class I deacetylases like
HDAC3 that account for physiological enzymatic activity in the
complex [10]. While the catalytic activity of the HDAC4 domain
remains controversial, the domain itself is critical for recruiting
HDAC3.
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6612While the sufficiency of the N-terminal portion of HDAC4 for
nucleo-cytoplasmic shuttling and transcription repression has been
demonstrated in in vitro systems, it has not been demonstrated that
the N-terminal portion alone is sufficient for these functions in vivo.
In this report, we describe a mutant mouse line generated by viral
insertion that disrupted the C-terminal deacetylase domain while
preserving the N-terminal domain.
Results
The mouse HDAC4 gene was mutated by gene trapping in our
large-scale genome 5000
TM knockout effort [23,24]. A search of
the OmniBank
TM gene trap sequence database revealed several
mutated ES cell clones with transcriptional sequence tags
representing HDAC4. Five clones (OST37699, OST45739,
OST68099, OST364354, and OST361114) were further charac-
terized to determine the genomic location of the gene trap vector
insertion and predict the extent of mutagenicity provided by each
distinct gene trap mutation. Four of these clones were found to
insert within the first intron of HDAC4 (NM_207225.1). These
insertions occur prior to two possible alternate transcription start
sites (TSS) for HDAC4 in the mouse, (alternate TSS 1 within
intron 1 (representative EST BY272035) and alternate TSS 2
within intron 4 (representative mRNA AK029933)) therefore these
mutations were not expected to disrupt expression of all isoforms
of the HDAC4 gene. OST361114 was found to carry an insertion
toward the end of the HDAC4 open reading frame, within intron
16 (Figure 1a). This gene trap mutation was selected for mouse
production because it disrupted all transcript classes and occurred
within the conserved histone deacetylase domain such that this
domain’s function should be effectively disrupted in the mutant
animals. This mutation (HDAC4
DC) resulted in viable pups born
in the expected Mendelian ratio (Wt:169; Het:331; Hom
HDAC4
DC:146) that survived to adulthood and reproduced.
In light of the lack of generalized effects as compared to the
complete KO [6], we hypothesized that the insertion strategy
allowed for the expression of the N-terminal domain of the
protein, thus preserving the domains necessary for overall
development. RT-PCR analysis confirmed both the absence of
full length HDAC4 transcript and the presence of a HDAC4-
BGEO fusion transcript in the homozygous HDAC4
DC tissue
(Figure 1b). Sequencing of the fusion transcript predicts a
truncation of the HDAC4 protein after aa 747 (figure 1c).
Western analysis using several HDAC4 antibodies confirmed
absence of the full length protein in brain tissue from HDAC4
DC
animals (Figure 2). Additionally, an antibody (Ab) anti-aa528-629
identified a mutant-specific ,95 kDa protein consistent with
truncation of HDAC4, as the full length HDAC4 was about
140 kDa. Although expressed, this putative truncated protein is
found at much reduced levels compared to the full length protein
in wild type brain tissue. To further confirm this ,95 kDa protein
is indeed the HDAC4 product, we performed immuno-precipita-
tion by anti-HDAC4 Ab. (anti-aa528-629) followed by western
blot by anti-HDAC4 Ab. (anti-aa1-19). We found that the
,95 kDa protein was precipitated by anti-aa528-629 Ab., and
was recognized by anti-aa1-19 ab. (figure 3). The results confirm
that a partial product, representing the N-terminal fragment, of
HDAC4 is expressed in HDAC4
DC mice.
Further detailed phenotyping was performed (supplementary
methods S1) to address the in vivo function of HDAC4 which had
been precluded previously due to the early mortality of the
complete null line [6]. HDAC4
DC mice appeared generally normal
in terms of weight, length, as well as in a battery of physiological,
metabolic, behavioral and histological assays at 8–14 weeks of age.
A comprehensive phenotypic analysis (including a subset of
behavioral tests derived from the Irwin screen) revealed no
notable abnormalities across a wide range of behaviors as well as
assays for cardiac, immune system, endocrine, and ophthalmic
function (as an example, the phenotypic screen of VGLUT1 mice
is accessible at: (http://www.informatics.jax.org/external/ko/
lexicon/2383.html). At 12 months of age male, but not female,
HDAC4
DC mice were smaller in size (WT 51.665.07 g,
HDAC4
DC 34.0462.8 g, P=0.01, t-test).
HDAC4
DC mice did not show enlarged brains or exencephaly
as has been reported previously for HDAC4 null mice [6].
Detailed histopathological analysis revealed no abnormalities in
the HDAC4
DC brains (supplementary figure S1). In order to assess
if the observed behavioral phenotype (below) was due to a subtle
spinal cord abnormality or due to vertebral bone or muscle
malformation, we carried out detailed histological analysis of the
spinal cord, the vertebral column, and the vertebral muscles
(supplementary figure S2). There were no differences noted in the
HDAC4
DC animals compared to littermate controls.
Behavioral testing revealed specific phenotypic differences
(Table 1). Increased latency to respond in the hot plate assay
was evident and was observed in two different cohorts. This
analgesic-like effect was noted in both sexes. In addition,
subsequent hot plate testing on the second cohort of mice, one
month after the initial test, confirmed and highlighted the
persistence of the phenotype across age, test experience as well
as generations (fig. 4). This effect was specific to an acute thermal
nociceptive stimulus since there was no difference between
genotypes in either phase of the formalin test (data not shown).
Some of the mice from cohort 2 (12/gender/genotype) were
subsequently tested (at 5 months) in the open field assay (OF) to
determine whether possible changes in activity levels could
contribute to the effects observed in the hot plate test. The female
HDAC4
DC mice traveled a greater distance in the OF than WT
females (WT 15386240.5 cm, HDAC4
DC 33496464.7 cm,
t(22)=3.46, P,0.01 t-test); there was no difference in total
distance between the males (WT 16656183.6 cm, HDAC4
DC
22056294.4 cm, t(22)=1.56, P=0.13) indicating that changes in
activity do not confound the acute pain phenotype.
During this later hot-plate testing, a number of the HDAC4
DC
mice (10/26) exhibited spontaneous seizures. Seizure-like activity
was also observed in (2/11) control mice. Seizures also occurred in
the home cage (supplementary data video S1, S2, S3 & S4), when
the cage was opened, or after mice were handled (supplementary
video S5). In most cases seizure activity was preceded by eye
blinking and consisted of head tilt (up), eye closure, full body
muscle spasms, followed by falling onto the side and continuing to
spasm for 1–10 sec. Once these symptoms had subsided and
animals righted themselves, they often showed residual ear and eye
twitches (supplementary data video S2). Some of the HDAC4
DC
mice also exhibited unilateral eye blinks and ear twitches in the
absence of overt tonic-clonic seizures, suggesting additional minor
seizure activity.
To more directly correlate the behavioral convulsions with
neuronal activity, some of these mice underwent EEG/EMG
telemetric monitoring before, during, and after handling. Two
mutants in which behavioral convulsions had not been noted and
four mutants with observed convulsions were tested along with five
control littermates. During continuous monitoring, mice were
taken out of the cage and gently handled. Two of the mutant mice
with a previous history of convulsion exhibited it again on
handling, while one without a history of behavioral convulsion,
also exhibited generalized tonic seizure. None of the five WT mice
tested exhibited abnormal EEG activity after handling. The
Phenotype of HDAC4
DC Mice
PLoS ONE | www.plosone.org 2 August 2009 | Volume 4 | Issue 8 | e6612Figure 1. A. Diagram of the mutated HDAC4 locus. Genotyping and RT-PCR primers are indicated by arrows, as described in the methods. Primers in
Exons 14 and 16 are used for RT-PCR to assay the endogenous transcript in wildtype and mutant mice. Primers in the LTR and intron (solid line) are
used to genotype the wildtype and mutant mice. B. RT-PCR analysis of wildtype (+/+) and HDAC4
DC (2/2) mice. Kidney and spleen tissue was
analyzed from one +/+ and one 2/2 mice. Each sample includes a negative control without Reverse Transcriptase, an assay with Hdac4 primers
alone, and an assay that includes an internal positive control for Actin. C. Protein sequence of mouse HDAC4. Bold letters correspond to histone
deacetylase (HDAC) domain. Underlined amino acid sequence (aa 528-629) is equivalent to the region of human HDAC4 antigen (human aa. 530-631)
of Santa Cruz antibody. Asterisk * denotes the site of retroviral insertion, which would terminate protein translation and putatively produce a partial
protein of 1-747aa with molecular weight of 83.3 kDa.
doi:10.1371/journal.pone.0006612.g001
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convulsions was similar in all mice that exhibited behavioral
convulsion. The electrographic seizure (fig. 5B) activity started
with 10–20 sec of generalized cortical discharge with fast spiking,
followed by a 20–30 sec period of slow spiking, and was
terminated with 30–40 sec of EEG depression. Induction of c-
Fos is an early marker of neuronal activity and is a robust marker
of seizure activity [25]. c-Fos immunohistochemistry, performed
one hour after handling, on brain sections of 5 animals of WT or
HDAC4
DC revealed strong c-Fos expression in the dentate gyrus
of HDAC4
DC animals that had exhibited convulsions in the
preceding 60 minutes as compared to HDAC4
DC animals devoid
of convulsions (fig. 5C, D, E) or control WT animals (fig. 5F).
Overall, our EEG results suggest that seizures are exclusive to
HDAC4
DC mice. However, since our initial observations noted
convulsions in a few WT mice, and random instances of seizure
activity in transgenic mice have been previously reported [26], it
cannot be excluded that this behavior is magnified, rather than
produced, by our genetic modification.
Discussion
Our HDAC4
DC knockout phenotype indicates that the
deacetylase domain of HDAC4 is dispensable for proper gross
development of mice. In sharp contrast to the early mortality of
the complete HDAC4 knockout mice [6], our C-terminal deletion
resulted in viable mice that survived as long as we have observed
them - over one year. In vitro transfection studies have shown that
HDAC4 aa. 2-500 is sufficient to bind and repress Runx2
transcription activity [6] while Wang et al. [27] have demonstrated
that HDAC4 118-208 is sufficient to interact with and repress
MEF2C mediated transcription. Therefore it is highly likely that
the expressed HDAC4 1-747 retains its binding to and repression
of MEF2C and Runx2 in vivo, explaining the lack of chondrocyte
hypertrophy in our mutant mice.
Extensive deletion analysis and in vitro transfection studies have
also identified the minimum N-terminal protein domains of the
HDAC4 protein sufficient to interact with binding proteins for
nucleo-cytoplasmic trafficking, phosphorylation and recruitment
Figure 2. Western blot confirmation of partial HDAC4 protein in mutant animals. A: Western blot by anti-HDAC4 (Sigma, anti-aa1-19). B:
Western blot by anti-HDAC4 (CST, anti-surrounding aa. 10). In both A and B, 1, 2 are wt brain and 3, 4 are HDAC4
DC brain. 1, 3 are cytosol fractions and
2, 4 are nuclear fractions. In both A and B, it is clear to see the full length HDAC4 of ,140 kDa is absent in mutant brain labeled by open arrowhead.
C: western blot by anti-HDAC4 (Santa Cruz, anti-aa528-629). 1, 2, 5, 6 are wt brain and 3, 4, 7, 8 are HDAC4
DC brain (39,4 9 79 89 are longer exposure of
3, 4, 7, 8) and 1,2,3,4 are cytosol fractions and 5,6,7,8 are nuclear fractions. Arrow indicates the putative truncated protein of ,95 kDa produced by
viral insertion. The arrow in A marks the same size position but no truncated protein could be clearly seen. Arrow in B marks the same size position
but there is a strong cross reacting band present in both wt and HDAC4
DC, which block the possible revealing of the truncated protein in HDAC4
DC
mutants. The arrowhead in C marked an irrelevant protein cross-reacted with HDAC4 antibody that is slightly smaller than full length HDAC4 and is
present in both wild type and mutant.
doi:10.1371/journal.pone.0006612.g002
Phenotype of HDAC4
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aa 119-208 is sufficient to interact with MEF2 and HDAC1 [4,8].
While HDAC4 by itself lacks nuclear transport capabilities,
evidence exists for MEF2 translocating HDAC4 to the nucleus
where transcription repression is brought about by recruiting other
HDAC’s like HDAC1 [8]. Conversely phosphorylation of
HDAC4 by calcium-calmodulin kinases (CAMKIV) [14], or
CAMKII [16], or CAMKI [19] recruits the phospho-binding
protein 14-3-3 and the HDAC4/14-3-3 complex is efficiently
exported out of the nucleus [12,13] preventing further repression.
The phosphorylation sites of HDAC4 at Ser246, Ser467 and
Ser632, and the 14-3-3 interaction site are also restricted to the N-
terminal region such that a minimum of aa 1-660 is sufficient for
HDAC4 to be trafficked in a nuclear-cytoplasmic manner [16–
19]. Thus aa 1-747, retained in our HDAC4
DC, encompasses all
the necessary functional domains, for efficient nuclear import-
export and nuclear repression, required for bone development and
for overall gross development.
It is surprising that the low expression of HDAC4
DC protein had
no observable impact on bone development. Arnold et al. [1] had
observed that the precocious ossification in HDAC4 null animals is
mostly rescued by a single allele deletion of MEF2C. Conversely
the MEF2C +/2 phenotype of delayed ossification has been
shown to be rescued by deletion of the repressing HDAC4
suggesting an allele balance between HDAC4 and MEF2C
capable of rescuing the bone phenotype. HDAC4
DC animals did
not show reduced expression of MEF2C protein as analyzed by
western blot (data not shown). Further quantitative analysis of
protein expression in HDAC4
DC animals will have to be
performed to address this question.
HDAC4
DC animals lack the histone deacetylase domain
(HDAC domain) and the nuclear export signal. The integrity of
the catalytic domain of HDAC4 is necessary for recruiting the
HDAC3 N-CoR repressor complex and for subsequent deacety-
lase activity of the complex, but the deacetylase activity of HDAC4
is at best minimal [9,11]. However, an in vivo function of the
catalytic domain of type IIa HDAC’s was confirmed by
overexpression, in the mouse striatum, of HDAC5 transcripts in
a cocaine reward model. The N-terminal domain was not able to
mimic the attenuation in cocaine reward behavior observed after
over-expression of full-length HDAC5. However, expression of the
catalytic domain by itself replicated the effect shown by the full
length protein [28]. Similar viral vector overexpression of full
length HDAC4 in the striatum of mice led to reduced levels of
histone H3 acetylation in the tissue and decreased the rewarding
effects of cocaine in the place conditioning assay [29]. These in vivo
results indicate a physiological requirement for this domain [28]
and leads us to predict that HDAC4
DC mice would show
hypersensitized responses in a chronic cocaine administration
model.
It has been shown that the c-terminus of human HDAC4
contains a nuclear export activity [14]. If this were the only means
for HDAC4 nuclear export, we would expect nuclear accumula-
tion of the protein in HDAC4
DC mice. Nuclear accumulation of
HDAC4 has been implicated in several pathways of regulation of
neuronal cell death [30] and in vitro such nuclear accumulation has
resulted in cerebellar granule neuron death. In the HDAC4
DC
mice no neuronal cell loss is apparent in any of the brain regions
Figure 3. Immunoprecipitation by anti-HDAC4 antibody (Santa
Cruz, anti-aa. 528-629) followed by western blot by anti-
HDAC4 (Sigma monoclonal antibody, anti-aa. 1-19). 1, 2 are wts
and 3, 4 are HDAC4
DC mutants. 1, 3 are inputs for IP and 2, 4 are IP
products. The ,95 kDa protein (arrow) was immunoprecipitated by
Santa Cruz anti-HDAC4 and then was detected by the Sigma HDAC4
antibody in western blot. The fact that ,95 kDa protein contained both
recognition regions of two different HDAC4 antibodies further
supported its HDAC4 origin.
doi:10.1371/journal.pone.0006612.g003
Table 1. Initial behavioral characterization of HDAC4
DC mice.
WT HDAC4
DC
Open Field
Total distance (cm) 233261150 (8) 27506838 (8)
Center Time 2936148 (8) 2796100 (8)
Rearing 38631 (8) 55634 (8)
Basal Body Temperature, uC 35.960.5 (8) 35.560.7 (8)
Stress-induced Hyperthermia 1.360.7 (4) 1.6560.65 (4)
Inverted Screen
Fell down (ratio) 0/8 0/8
Climbed up (ratio) 4/8 8/8
Marble Burying 8.166.7 (8) 11.368.8 (8)
Acoustic Startle Response 3956189 (19) 4576269 (22)
PPI (%)
pp4 19.5628 (15) 25628 (18)
pp8 25629 (15) 34626 (18)
pp12 51617 (15) 47623 (18)
pp20 74611 (15) 72618 (18)
Tail suspension
Immobility (sec) 148636 (8) 118635 (8)
Hot Plate
Latency (sec) 8.562.6 (8) 20.567.5 (8) **
Data are expressed as mean6SD (N). Statistical analysis was performed for all
assays. * 2p,0.05, ** 2p,0.01 from WT littermates (unpaired t-test).
doi:10.1371/journal.pone.0006612.t001
Phenotype of HDAC4
DC Mice
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assays of brain tissue showed HDAC4 in both nuclear and
cytoplamic regions (figure 2) indicating that the c-terminal nuclear
export signal is dispensable for appropriate nucleo-cytoplasmic
trafficking of the protein.
HDAC4
DC mice were generally normal at 2–4 months of age
except for a strong reduction in response to a thermal nociceptive
stimulus. It is interesting to note that Runx1 knockout mice also
show a similar analgesic-like effect [31], where Runx1 was shown
to regulate expression of many nociceptive receptors or ion
channels as well as the lamina specific innervation pattern of
nociceptive afferents in the spinal cord. The Runx (runt-related
protein) family of transcription factors play important roles in cell
differentiation and tissue development. HDAC family members
bind to Runx2 and act as transcription co-repressors in skeletal
development [6,32,33]. Runx1 can recruit a number of class I and
II HDACs as transcriptional co-repressors [34,35] and is proposed
to be a candidate interacting protein for HDAC4 based on its
homology to Runx2/3 [36]. It is possible that HDAC4 together
with Runx1 co-regulates expression of specific nociceptors. There
was no alteration in acute chemical (formalin) induced nociception
in our mutant, therefore we further hypothesize that HDAC4
regulates thermal nociceptors specifically, as has been described
for Runx1. The normal responses to formalin-induced nociception
also indicate that neuronal circuits for acute pain sensation and
muscle reflexes for paw movement are not affected by the loss of
the HDAC4 catalytic domain.
As the mice aged beyond 20 weeks the HDAC4
DC mice
exhibited spontaneous convulsions that appeared to be exacerbat-
ed by handling. The factors leading to development of seizures are
largely unknown. The HDAC4
DC mouse may serve as a novel
genetic model to reveal the physiological and cellular mechanisms
leading to epilepsy. It is possible that loss of the C-terminal
deacetylase domain of HDAC4 leads to a dysfunction of synaptic
transmission and neuronal excitability that underlie seizure. This
seems somewhat at odds with the fact that the HDAC inhibitor,
valproic acid [37], is a clinically effective anti-convulsant. It is not
known if valproic acid acts on the novel enzymatic domain of
HDAC4 in vitro or in vivo. Further study is required to reveal the
interplay between HDAC4 and epilepsy.
In summary, our work confirms the N-terminal sufficiency of
HDAC4 for transcriptional repression regulating skeletogenesis in vivo.
HDAC4 has been implicated in neuronal function and survival
[30,38–40] and our work supports specific behavioral functions for
HDAC4 in vivo. Although it is very possible that our behavioral
phenotypes are a result of the loss of the putative deacetylase domain,
they could also be due to the low expression of the N-terminal domain.
Additional mutagenesis studies will be required to examine this.
Materials and Methods
Generation of HDAC4
DC animals
HDAC4
DC mice were generated at Lexicon Pharmaceuticals,
by gene trapping in ES cells, identification of trapped genes by
using OmniBank
TM Sequence Tags (OSTs) and characterization
of retroviral gene-trap vector insertion points as previously
[23,24]. OmniBank ES cell clone OST361114 was used to
generate HDAC4
DC mice as described in PMID [23]. All mice
were of mixed genetic background (129SvEvBrd and C57Bl/6J).
RT-PCR confirmation of the mutation was performed on RNA
extracted from kidney and spleen of both a homozygous mutant
mouse and a wildtype littermate. Primers were from the fourteenth
and sixteenth coding exons: 59-CAC ACA CTC CTC TAC GGC
ACA AAT C and 59-ACC TTG AAG ACC AGC TCC ACT
ACA CA. This yielded an RT-PCR product of 201 bp. Gene trap
vector VICTR37 sometimes generates a splicing artifact. Se-
quence analysis of the resulting RT-PCR product shows a
frameshift and truncation of the endogenous ORF. Mice were
genotyped by PCR. The wildtype locus yields a PCR product of
309 bp using primers 59-GTA AAG GCC TGT GTC TTT GAC
TTC C and 59-ACC CCA GGA TTC CAG GCT GCT ATC A.
Figure 4. Latency to respond in Hot Plate assay. A. Latency to
respond in females (cohort 1) was significantly higher in the HDAC4
DC
mice, compared to WT littermate controls (t(29)=4.0, *** 2p,0.001 –
unpaired two-tailed t-test). B. Latency to respond was significantly
higher in the HDAC4
DC mice (cohort 2), compared to WT littermate
controls (t(14)=2.74, * 2p,0.05 for females, and t(30)=4.38, ***
2p,0.001 for males– unpaired two-tailed t-test with Welch’s correc-
tion). C. Latency to respond during repeated hot plate testing in the
second cohort of mice. *** 2p,0.0001 from WT littermates of the same
sex (t(30)=6.03 for females, and t(30)=5.58 for males, unpaired two-
tailed t-test).
doi:10.1371/journal.pone.0006612.g004
Phenotype of HDAC4
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59-AAA TGG CGT TAC TTA AGC TAG CTT GC and 59-
ACC CCA GGA TTC CAG GCT GCT ATC A.
Ethics Statement
Research related to use of mice was conducted under guideline
of Lexicon Institutional Animal Care and Use Committee. All
work was performed in accordance with Public Health Service
policies and the Animal Welfare Act.
Behavioral Testing
Only the assays in which significant differences were observed
are described below (for descriptions of other assays see
Supplementary Methods S1). Behavioral assays were performed
on multiple cohorts of mice. Cohort -1 consisted of 12 female WT
and 19 female HDAC4
DC tested in the HP and formalin assays;
cohort-2 consisted of 16 male WT, 16 male HDAC4
DC, 19 female
WT, and 13 female HDAC4
DC tested in the open field, HP and
formalin assays; Hot plate testing was performed twice on the
second cohort of mice – prior to the formalin test and then again
one month after the formalin test, to see if observed phenotype was
still present after additional testing history.
Locomotor activity
Locomotor and exploratory behaviors were recorded with
twelve Digiscan open field (OF) apparatus and Versamax software
(Accuscan Instruments, Inc., Columbus, OH). A large arena
(42 cm642 cm) with infrared beams at three different levels was
Figure 5. A &B: EEG/EMG recordings of a mutant mice exhibited behavioral convulsion after handling. (A) Continuous tracing of monopolar epidural
EEG (upper trace) and trapezius EMG (lower trace) recording during waking. (B) shows generalized cortical discharge induced by gentle handling of
the same mouse. The seizure activity is characterized by fast spiking concurrence with muscle potential during the tonic phase. The termination of
the convulsion is characterized by EEG voltage depression after a slow spike transition. C–F: c-Fos expression in the hippocampus of WT and
HDAC4
DC mice 60 minutes after handling and convulsions exhibited by the HDAC4
DC. C) Very few c-Fos positive cells (brown) are seen in a HDAC4
DC
devoid of seizures. D) Dentate gyrus (dg) neurons are positive for c-Fos in the HDAC4
DC animals expressing convulsions (D,E) but absent in the WT
animal (F).
doi:10.1371/journal.pone.0006612.g005
Phenotype of HDAC4
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vertical movement (rearing), and investigation into the 4 holes in
the floor of the open-field (hole poke). Two florescent lamps
positioned over each chamber provided light levels of 800 lux in
the center of each open field arena. Each animal was placed in the
center of the open field and its activity was measured for 20
minutes. The total distance traveled (cm), vertical movement
number (rearing), number of hole pokes, time spent in the center
of the OF (time-in-center), distance traveled in the center of the
OF (center distance), and center/total distance ratio over the
intervals were recorded using Versadat program (Accuscan
Instruments). The OF center area measured 20620 cm.
Hot Plate test to assess nociceptive response to an acute
thermal pain stimulus was performed using a Columbus
Instruments Hotplate Analgesia meter (model 1440). The hot
plate was set to 55u C and controlled to within 0.1u C. The size of
the heated surface area was 100610060.750. The response time for
each animal (hind-paw flinching) was automatically recorded by
the computer when the experimenter blind to genotype of the
animals tested pressed the stop button on the chamber.
Biochemistry
HDAC4 antibodies were purchased from Santa Cruz (sc-11418,
anti-aa. 528-629, rabbit), Cell Signaling Technology (#2072, anti-
surrounding aa. 10, rabbit) and Sigma (anti-aa. 1-19, mouse
monoclonal, clone HDAC-144). For tissue fractionation, mouse
brains were dissected and homogenized in 0.32 M sucrose, 1 mM
NaHCO3, 16protease inhibitor, spun at 1400 g for 10minutes to
obtain pellet (P1, nuclear fraction) and supernatant (S1, cytosol
fraction). P1 was further extracted by RIPA buffer (10 mM Tris,
1 mM EDTA, 150 mM NaCl, 1% Triton, 1% DOC, 0.1% SDS)
and spun at 18,000 g for 20 min to obtain supernatant (extracted
P1). Protein concentration was determined and 20 micorgrams of
protein were loaded to SDS-PAGE for western blotting. For
immunoprecipitation the dissected mouse whole brain was directly
homogenized in RIPA buffer, the insoluble material was removed
by centrifugation and 2 milligrams of protein were used for
immunoprecipitation. The antibodies were used for western or
immunoprecipitation at dilution recommended by their suppliers.
EEG/EMG Monitoring
Twelve male mice (6 months of age, 6 HDAC4
DC and 5 wts)
were used for monitoring EEG/EMG before, during and after
handling. Mice were surgically implanted with F-20-EET
biopotential transmitters (DSI, Wisconsin US) as described by
Weiergraber et al [41]. Briefly, mice were anesthetized with
isoflurane. After the transmitter was place on top of the intestines,
biopotential leads were directed caudally to a dorsal neck incision
through a subcutaneous tunnel. The animal was then placed in a
stereotaxic apparatus for cranial immobilization. The skull was
perforated through the bone but before the dura membrane at
2 mm either side of the sagittal suture and 1 mm posterior to the
bregma suture on left side and 1 mm anterior to the lambda suture
on the right for ground and EEG leads implantation. EMG leads
were secured in cervical trapezius muscles. Following 10–14 days
of recovery from surgery and habituation, data were continuously
acquired in EEG lab for 24 hours on a DATAQUEST ART 4.0
(Data Sciences International). EEG and EMG signals were
amplified and filtered at 0.3–30 Hz for EEG and 30–300 Hz for
EMG, digitized at a sampling rate of 250 Hz. After collection,
EEG/EMG recordings were manually inspected for epileptic
activity in aid of SLEEPSIGN software (KISSEI COMTEC CO.).
Pathology. Mice were anesthetized with Avertin. After
incision of the vena cava inferior, mice were perfused with
Harleco bouin fixation fluid (EMD chemicals, Inc., Gibbstown,
NJ) or 4% paraformaldehyde through the left ventricle. Tissues
were collected from HDAC4
DC mice and litter-mate control mice
and were immersion fixed in 10% neutral buffered formalin.
Bones were decalcified in 0.5 M EDTA pH 8.0 (Ambion, Austin,
TX) for 7 days and all tissues were embedded in paraffin,
sectioned at 4 mm and mounted on positively charged glass slides
(Superfrost Plus, Fisher Scientific, Pittsburgh, PA) and stained with
hematoxylin and eosin (H&E) for histopathologic examination.
Several unstained sections both at 4 mm and 8 mm were collected
on positively charged slides for future assays. The FD Rapid Timm
stain kit (FD NeuroTechnologies, Inc., Baltimore, MD) was
utilized on 8 mm sections according to the manufactures suggested
protocol to compare neuropils in both the wild type and mutant
mice. The Luxol Fast Blue kit (Poly Scientific, Bay Shore, NY) was
used on 8 mm sections according to the manufactures suggested
protocol to look for any differences in myelination in the wild type
and mutant mice.
Immunohistochemistry. Formalin-fixed, paraffin-
embedded tissue sections at 4 mm and mounted on positively
charged glass slides (Superfrost Plus, Fisher Scientific, Pittsburgh,
PA) were first deparaffinized in xylene and re-hydrated in PBS
before incubating in the primary antibody. Commercially
available c-Fos (Sigma-Aldrich, St. Louis, MO, cat # F7799)
and MHC, slow and fast, (Novocastra Laboratories LTD.,
Newcastle, UK) were used to detect expression in the tissues of
wild type and mutant mice. Mice intended for c-Fos expression
analysis were collected 60 minutes after an episode of convulsion
and prefused with 4% paraformaldehde and processed for paraffin
embedding and sectioning. Both Myosin Heavy chain antibodies
required antigen retrieval. Briefly, sections were immersed for 20
minutes in AR10 buffer, pH 10.0 (Biogenex, San Ramon, CA).
After a 20 minute cool down the MHC slides were processed
further. Endogenous peroxidase activity was blocked by
incubation in 3.0% hydrogen peroxide in PBS for 5 min. Tissue
sections were then blocked with 20% normal horse serum for 10
minutes and then primary antibodies (either 1:25 mouse anti
MHC slow, 1:25 mouse anti MHC fast or 1:500 Rabbit anti c-Fos)
were applied for 1 hour at 37 degrees centigrade. After rinsing,
sections were incubated for one hour in a 1:500 dilution of the
biotinylated secondary antibody (Horse anti-Mouse IgG, or Goat
anti-Rabbit IgG, Vector, Burlingame, CA). Bound antibodies were
detected by an avidin-biotin complex method (Elite ABC Kit,
Vector) with 3,39-diaminobenzidine as chromogenic substrate
following the manufacturer’s instructions. Negative controls
included substitution of non-immune serum for the primary
antibody and omission of the primary antibody. After
counterstaining with hematoxylin, sections were mounted with
Permount (Fisher Scientific, Pittsburgh, PA).
Supporting Information
Methods S1 Behavioral assays
Found at: doi:10.1371/journal.pone.0006612.s001 (0.03 MB
DOC)
Figure S1 Histology of Brain: in each section left half is from
WT and right half is from HDAC4
DC mice. A and C is Timm
staining of a coronal section through the hippocampus of a WT
and an HDAC4
DC mice. B, D, E and F is H&E staining of sections
of a WT and a HDAC4
DC mice. B & D shows the hippocampus is
similar in WT and a HDAC4
DC mice, E shows the cerebellar
flocculus and F compares the spinal cord section of a WT and a
HDAC4
DC mice.
Found at: doi:10.1371/journal.pone.0006612.s002 (0.96 MB TIF)
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PLoS ONE | www.plosone.org 8 August 2009 | Volume 4 | Issue 8 | e6612Figure S2 Histology of vertebral muscles and bone; A, C & E is
WT; B, D & F is HDAC4
DC mice. A&B shows IHC for MHC slow
chain, C&D is IHC for MHC fast chain in lumbar vertebral
muscles. E&F shows luxol fast blue stained lumbar vertebrae and
spinal cord.
Found at: doi:10.1371/journal.pone.0006612.s003 (1.55 MB TIF)
Video S1 Behavioral convulsions in the home cage. The videos
sequentially record A) a cage of 5 male mice (3 mutant, 2 WT).
White, black and one of the agouti mice are HDAC4 mutants and
the black male mutant is convulsing. Notice that the animals are
otherwise normal in body weight and general health.
Found at: doi:10.1371/journal.pone.0006612.s004 (16.21 MB
MPG)
Video S2 Behavioral convulsions in the home cage. Male mouse
from video S1 recovering from convulsions: the mouse is
exhibiting ear twitching before complete recovery.
Found at: doi:10.1371/journal.pone.0006612.s005 (10.21 MB
MPG)
Video S3 Behavioral convulsions in the home cage. C) A female
black mutant mouse is exhibiting convulsions in a cage of 5 female
mice (3 mutant, 2 WT) of which both of the black mice and one of
the white mice are mutants. Notice that the animals are otherwise
normal in body weight and general health.
Found at: doi:10.1371/journal.pone.0006612.s006 (10.14 MB
MPG)
Video S4 Behavioral convulsions in the home cage. D) Female
mouse from Video S3 is recovering from convulsions. Notice that
the animals are otherwise normal in body weight and general
health.
Found at: doi:10.1371/journal.pone.0006612.s007 (10.09 MB
MPG)
Video S5 Handling induced seizure activity in HDAC4
DC
mouse. The video shows a ,20 week old female HDAC4 mutant
mouse convulsing when placed in the open field apparatus.
Found at: doi:10.1371/journal.pone.0006612.s008 (0.87 MB
MPG)
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